Holding(s) in Company

11 Jun 2007 11:56

Phytopharm PLC11 June 2007 TR-1: notification of major interests in shares 1. Identity of the issuer or Phytopharm plcthe underlying issuer of --------------------existing shares to which votingrights are attached:-------------------------------2. Reason for the notification (please tick the appropriate box or boxes)-------------------------------------------- -------An acquisition or disposal of voting rights (X) An acquisition or disposal of financial instruments which may result in the ( )acquisition of shares already issued to which voting rights are attached ---------------------------------------------------An event changing the breakdown of voting rights ( )-------------------------------------------- -------Other (please specify):___________________________________________ ( )-------------------------------------------- -------3. Full name of person(s) AXA S.a, 25 Avenue Matignon, 75008 Paris and its group of companiessubject to the notification --------------------obligation:-------------------------------4. Full name of shareholder(s)(if different from 3.): ---------------------------------------------------5. Date of the transaction (and 07/06/2007date on which the threshold is --------------------crossed or reached ifdifferent)-------------------------------6. Date on which issuer 08/06/2007notified: ---------------------------------------------------7. Threshold(s) that is/arecrossed or reached: ---------------------------------------------------8. Notified details:------------------------------- -------------------- A: Voting rights attached to sharesClass/type Situation previous to the Resulting situation after the triggeringof shares Triggering transaction transactionif possibleusing the Number of Number of Number of Number of voting % of votingISIN CODE Shares Voting shares rights rights Rights Direct Direct x Indirect xi Direct IndirectOrdinary 1Pence 3,328,148 3,328,148 11,000 11,000 3,327,148 0.02 5.98GB000686972 B: Financial InstrumentsResulting situation after the triggering transactionType of Expiration Exercise/ Number of voting rights that may % offinancial date Conversion be acquired if the instrument is votinginstrument Period/ Date exercised/ converted. rights Total (A+B)Number of voting rights % of voting rights3,338,148 6.00% 9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: Name of the Company/Fund Number of Shares % of issued share capitalAXA UK Investment Co ICVC UKSmaller Companies Fund 620 0.00111IndirectSun Life Pensions ManagementLtd 11,000 0.01978DirectAXA Framlington Equity Income 1,851,612 3.32986IndirectAXA Framlington Biotech 1,052,631 1.89301IndirectFramlington onshore privateclients 396,483 0.71302IndirectFramlington onshore privateclients 25,802 0.04640Indirect Total direct 11,000 0.01978 Total Indirect 3,327,148 5.98340 Total 3,338,148 6.00318 Proxy Voting:10. Name of the proxy holder:11. Number of voting rights proxy holder will cease to hold:12. Date on which proxy holder will cease to hold voting rights: 13. Additional Notification using the total voting rights figure ofinformation: 55,606,30914. Contact name: Zoe McGowan, Company Secretary15. Contacttelephonenumber: 01480 437697 This information is provided by RNS The company news service from the London Stock Exchange